75A50124F61011↗
Sanofi Vaccines US Inc. received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $681.0K obligated so far for health r&d services; health care services; applied research. Its period of performance ended 2024-12-15.
Key facts · data as of Oct 26, 2026
- Recipient
- Sanofi Vaccines US Inc.
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Obligated to date
- $681.0K
- Potential value
- $681.0K
- Ends
- 2024-12-15
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75A50124F61011, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75A50124F61011_7505_75A50122D00003_7505
Sanofi Vaccines US Inc.: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys
ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/2021
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under 75A50122D00003
- Where the work is
- Monroe, PA · district PA-08
- Funding law
- COVID-19 laws
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
2 actions since 2024-09-04. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-12-17 | P00001 | Close-out | $0 | ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/2021 |
| 2024-09-04 | 0 | $681.0K | ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/2021 |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗